Stem Cell Market Research Reports & Industry Analysis
Cells must meet very specific criteria in order to be termed stem cells. They must: produce copies themselves; proliferate at a rapid rate; and display certain proteins on their surface that indicate a capacity to differentiate into other tissues, such as bone and cartilage. A stem cell line is a group of cells that all descend from a single original stem cell. Symmetric division gives rise to two identical daughter cells both endowed with stem cell properties. Asymmetric division produces only one stem cell and a progenitor cell with limited self-renewal potential.
Stem Cell Industry Research & Market Reports
-
Regenerative Medicine Market by Type (Cell-Based Immunotherapy & Cell Therapy Products, Gene Therapy Products, Small Molecule & Biologic), Application (Cardiovascular, Diabetes, Musculoskeletal Disorders) - Global Forecast 2024-2030
... USD 24.01 billion in 2023 and expected to reach USD 28.82 billion in 2024, at a CAGR 20.13% to reach USD 86.73 billion by 2030. Global Regenerative Medicine Market FPNV Positioning Matrix The FPNV Positioning ... Read More
-
Cell Culture Market by Product (Consumables, Equipment), Application (Biopharmaceutical Production, Cell Banking, Diagnostics) - Global Forecast 2024-2030
... 33.05 billion in 2024, at a CAGR 15.36% to reach USD 77.98 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Cell Culture Market. It offers a comprehensive assessment ... Read More
-
Stem Cells Market by Cell Source (Adipose Tissue-Derived Mesenchymal Stem Cells, Bone Marrow-Derived Mesenchymal Stem Cells, Cord Blood/Embryonic Stem Cells), Type (Allogeneic Stem Cell Therapy, Autologous), Therapeutic Application - Global Forecast 2024-
... Market size was estimated at USD 237.23 million in 2023 and expected to reach USD 277.13 million in 2024, at a CAGR 16.91% to reach USD 708.40 million by 2030. Global Stem Cells Market FPNV ... Read More
-
Cell Banking Outsourcing Market by Type (Master Cell Banking, Viral Cell Banking, Working Cell Banking), Cell Type (Non-Stem Cell, Stem Cell), Phase - Global Forecast 2024-2030
... USD 12.64 billion in 2023 and expected to reach USD 14.57 billion in 2024, at a CAGR 15.59% to reach USD 34.87 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in ... Read More
-
Rat & Mouse Model Market by Model Type (Conditioned or Surgically Modified Rats, Genetically Modified Rats, Hybrid or Congenic Rats), Technology (CRISPR, Embryonic Stem Cell Injection, Microinjection), Care Product, Service, Therapeutic Area, End-User - G
... Forecast 2024-2030 The Rat & Mouse Model Market size was estimated at USD 2.26 billion in 2023 and expected to reach USD 2.37 billion in 2024, at a CAGR 5.41% to reach USD 3.27 billion ... Read More
-
Upstream Bioprocessing Market by Product (Bags & Containers, Bioreactors & Fermenters, Bioreactors Accessories), Workflow (Cell Culture, Cell Separation, Media Preparation), Use Type, Mode - Global Forecast 2024-2030
... USD 10.70 billion in 2023 and expected to reach USD 12.09 billion in 2024, at a CAGR 13.54% to reach USD 26.03 billion by 2030. Global Upstream Bioprocessing Market FPNV Positioning Matrix The FPNV Positioning ... Read More
-
Umbilical Cord Blood Processing Products Market by Product (CD Markers, Cell Culture Devices, Cell Culture Reagents), End-Users (Private Banks, Public Banks) - Global Forecast 2024-2030
... at USD 1.53 billion in 2023 and expected to reach USD 1.69 billion in 2024, at a CAGR 10.93% to reach USD 3.16 billion by 2030. Global Umbilical Cord Blood Processing Products Market FPNV Positioning ... Read More
-
Microcarriers Market by Product (Consumables, Equipment), Application (Biologics Manufacturing, Cell Therapy, Vaccine Manufacturing), End User - Global Forecast 2024-2030
... USD 2.37 billion in 2024, at a CAGR 9.99% to reach USD 4.22 billion by 2030. Global Microcarriers MarketMicrocarriers are small spherical beads made from materials such as dextran, polystyrene, gelatin, or glass that provide ... Read More
-
North America Cell and Gene Therapy Manufacturing Services Market Forecast to 2030 - Regional Analysis - by Type [Cell Therapy (Autologous and Allogenic) and Gene Therapy (Viral and Non-Viral Vector)], Indication (Cancer, Orthopedics, and Others), Application (Clinical Manufacturing and Commercial Manufacturing), and End User [Pharmaceutical and Biotechnology Companies and Contract Research Organization (CROs)]
... Application (Clinical Manufacturing and Commercial Manufacturing), and End User [Pharmaceutical and Biotechnology Companies and Contract Research Organization (CROs)] The North America cell and gene therapy manufacturing services market is expected to grow from US$ 4,153.27 ... Read More
-
Autologous Stem Cell & Non-Stem Cell Based Therapies Market by Type (Autologous Non-Stem Cells, Autologous Stem Cells), Indication (Cancer, Cardiovascular Disease, Neurodegenerative Disorders), End-User - Global Forecast 2024-2030
... Based Therapies Market size was estimated at USD 7.17 billion in 2023 and expected to reach USD 8.22 billion in 2024, at a CAGR 14.78% to reach USD 18.83 billion by 2030. FPNV Positioning Matrix ... Read More
-
Cellular Immunotherapy Market by Type (CAR T-Cell Therapy, Dendritic Cell Therapy, NK Cell Therapy), Indication (B-Cell Malignancies, Liver Cancer, Prostate Cancer), Technology Type, End-Use - Global Forecast 2024-2030
... at USD 11.23 billion in 2023 and expected to reach USD 14.02 billion in 2024, at a CAGR 25.34% to reach USD 54.60 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal ... Read More
-
South & Central America Cell and Gene Therapy Manufacturing Services Market Forecast to 2030 - Regional Analysis - by Type [Cell Therapy (Autologous and Allogenic) and Gene Therapy (Viral and Non-Viral Vector)], Indication (Cancer, Orthopedics, and Others), Application (Clinical Manufacturing and Commercial Manufacturing), and End User [Pharmaceutical and Biotechnology Companies and Contract Research Organization (CROs)]
... and Others), Application (Clinical Manufacturing and Commercial Manufacturing), and End User [Pharmaceutical and Biotechnology Companies and Contract Research Organization (CROs)] The South & Central America cell and gene therapy manufacturing services market is expected to ... Read More
-
Lysosomal Storage Diseases Market by Disease Type (Fabry Diseases, Gaucher's Diseases, Mucopolysaccharidosis), Type of Therapy (Enzyme Replacement Therapy, Stem Cell Therapy, Substrate Reduction Therapy), End User - Global Forecast 2024-2030
... size was estimated at USD 9.31 billion in 2023 and expected to reach USD 9.98 billion in 2024, at a CAGR 7.48% to reach USD 15.43 billion by 2030. FPNV Positioning Matrix The FPNV Positioning ... Read More
-
Paroxysmal Nocturnal Hemoglobinuria Treatment Market by Diagnostic Test (Bone Marrow Examination, Complete Blood Count Test, Flow Cytometry), Treatment (Blood Transfusion, Medication, Stem Cell Transplant) - Global Forecast 2024-2030
... estimated at USD 87.89 billion in 2023 and expected to reach USD 103.05 billion in 2024, at a CAGR 17.35% to reach USD 269.37 billion by 2030. Global Partner Relationship Management Market FPNV Positioning Matrix ... Read More
-
Stem Cell Therapy Market by Type (Allogeneic Stem Cell Therapy, Autologous Stem Cell Therapy), Cell Source (Adipose Tissue-Derived MSCs, Bone Marrow-Derived MSCs, Placental / Umbilical Cord-Derived MSCs), Therapeutic Application, End-User - Global Forecas
... Stem Cell Therapy Market size was estimated at USD 439.83 million in 2023 and expected to reach USD 493.20 million in 2024, at a CAGR 12.88% to reach USD 1,027.29 million by 2030. Global Stem ... Read More
-
Amyotrophic Lateral Sclerosis Treatment Market by Treatment (Medication, Stem Cell Therapy), Distribution Channel (Hospital Pharmacies, Retail Pharmacies) - Global Forecast 2024-2030
... 2023 and expected to reach USD 790.52 million in 2024, at a CAGR 7.73% to reach USD 1,237.05 million by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Amyotrophic Lateral ... Read More
-
Stem Cell Banking Market by Type (Cord Blood, Cord Tissue), Service (Analysis, Collection, Processing), Source, Application - Global Forecast 2024-2030
... expected to reach USD 16.98 billion in 2024, at a CAGR 17.22% to reach USD 44.24 billion by 2030. Global Stem Cell Banking Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating ... Read More
-
Hemoglobinopathies Market by Indication (Sickle Cell Disease, Thalassemia), Treatment (Blood Transfusion, Bone Marrow & Stem Cell Transplant, Chemotherapy), Diagnosis, End-User - Global Forecast 2024-2030
... 2023 and expected to reach USD 2.79 billion in 2024, at a CAGR 33.02% to reach USD 19.46 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Hemoglobinopathies Market. ... Read More
-
Nerve Repair & Regeneration Market by Product (Biomaterials, Neurostimulation & Neuromodulation Devices), Application (Direct Nerve Repair/Neurorrhaphy, Nerve Grafting, Neurostimulation & Neuromodulation Surgeries), End-User - Global Forecast 2024-2030
... estimated at USD 10.10 billion in 2023 and expected to reach USD 11.43 billion in 2024, at a CAGR 13.27% to reach USD 24.18 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is ... Read More
-
Europe Cell and Gene Therapy Manufacturing Services Market Forecast to 2030 - Regional Analysis - by Type [Cell Therapy (Autologous and Allogenic) and Gene Therapy (Viral and Non-Viral Vector)], Indication (Cancer, Orthopedics, and Others), Application (Clinical Manufacturing and Commercial Manufacturing), and End User [Pharmaceutical and Biotechnology Companies and Contract Research Organization (CROs)]
... (Clinical Manufacturing and Commercial Manufacturing), and End User [Pharmaceutical and Biotechnology Companies and Contract Research Organization (CROs)] The Europe cell and gene therapy manufacturing services market is expected to grow from US$ 1,879.77 million in ... Read More
-
Middle East & Africa T Cell Therapy Market Forecast to 2030 - Regional Analysis - by Modality (Research and Commercialized), Therapy Type [CAR T-cell Therapy and T-cell Receptor (TCR)-based], and Indication (Hematologic Malignancies and Solid Tumors)
... Tumors) The Middle East & Africa T cell therapy market was valued at US$ 73.14 million in 2022 and is expected to reach US$ 211.46 million by 2030; it is estimated to grow at a ... Read More
-
Asia Pacific T Cell Therapy Market Forecast to 2030 - Regional Analysis - by Modality (Research and Commercialized), Therapy Type [CAR T-cell Therapy and T-cell Receptor (TCR)-based], and Indication (Hematologic Malignancies and Solid Tumors)
... Asia Pacific T cell therapy market was valued at US$ 251.99 million in 2022 and is expected to reach US$ 882.72 million by 2030; it is estimated to grow at a CAGR of 17.0% from ... Read More
-
Apoptosis Market by Product Type (Assays, Instrument, Reagents), Technique (Cell Imaging & Analysis Systems, Flow Cytometry, Spectrophotometry), Application, End-user - Global Forecast 2024-2030
... and expected to reach USD 5.72 billion in 2024, at a CAGR 7.50% to reach USD 8.88 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Apoptosis Market. It ... Read More
-
Hunter Syndrome Treatment Market by Treatment (Enzyme Replacement Therapy, Hematopoietic Stem Cell Transplant), End User (Clinics, Home Healthcare, Hospitals) - Global Forecast 2024-2030
... in 2023 and expected to reach USD 1.17 billion in 2024, at a CAGR 8.06% to reach USD 1.87 billion by 2030. Global Hunter Syndrome Treatment Market FPNV Positioning Matrix The FPNV Positioning Matrix is ... Read More
-
Human Embryonic Stem Cells Market by Type (Pluripotent Stem Cells, Totipotent Stem Cells, Unipotent Stem Cells), Application (Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering), End-User - Global Forecast 2024-2030
... Market size was estimated at USD 848.35 million in 2023 and expected to reach USD 920.43 million in 2024, at a CAGR 8.98% to reach USD 1,549.81 million by 2030. Global Human Embryonic Stem Cells ... Read More
Research Assistance
